Cargando…

Prednisolone Co-Administered with Losartan Confers Renoprotection in Patients with IgA Nephropathy

BACKGROUND: Treatment options for progressive IgA nephropathy are limited. METHODS: We performed a small, randomized controlled trial to evaluate the effects of prednisolone (PSL, 30 mg/dL, gradually tapered to 5 mg/dL over two years) plus 50 mg/day of losartan (LST, an angiotensin II receptor block...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horita, Yoshio, Tadokoro, Masato, Taura, Kouichi, Ashida, Ryuichi, Hiu, Mayumi, Taguchi, Takashi, Furusu, Akira, Kohno, Shigeru
Formato:	Texto
Lenguaje:	English
Publicado:	Informa Healthcare 2007
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409178/ https://www.ncbi.nlm.nih.gov/pubmed/17497466 http://dx.doi.org/10.1080/08860220701260511

Ejemplares similares

Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70
por: Costantino, Valeria Victoria, et al.
Publicado: (2021)

Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014)

Pharmacokinetics of Orally Administered Prednisolone in Alpacas
por: Videla, Ricardo, et al.
Publicado: (2021)

Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
por: Maquigussa, Edgar, et al.
Publicado: (2018)

Nephroprotective effect of losartan in IgA model rat
por: Xing, Li, et al.
Publicado: (2019)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats.
por: Park, C. G., et al.
Publicado: (2001)

Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection
por: Riispere, Živile, et al.
Publicado: (2017)

The Renoprotective Effects of Docosahexaenoic Acid as an Add-on Therapy in Patients Receiving Eicosapentaenoic Acid as Treatment for IgA Nephropathy: A Pilot Uncontrolled Trial
por: Moriyama, Takahito, et al.
Publicado: (2017)

The renoprotective effects of pentoxifylline: beyond its role in diabetic nephropathy
por: Kapoor, Shailendra
Publicado: (2013)

Comprehensive renoprotective effects of ipragliflozin on early diabetic nephropathy in mice
por: Kamezaki, Michitsugu, et al.
Publicado: (2018)

Renoprotective effects of Gushen Jiedu capsule on diabetic nephropathy in rats
por: Zhang, Lei, et al.
Publicado: (2020)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Effect of losartan and spironolactone on triglyceride-rich lipoproteins in diabetic nephropathy
por: Srivastava, Anand, et al.
Publicado: (2016)

Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial
por: Li, Ping, et al.
Publicado: (2017)

Race/ethnicity and disease severity in IgA nephropathy
por: Hall, Yoshio N, et al.
Publicado: (2004)

Renoprotective effects of atorvastatin compared with pravastatin on progression of early diabetic nephropathy
por: Takazakura, Akiko, et al.
Publicado: (2015)

Early Renoprotective Effect of Ruxolitinib in a Rat Model of Diabetic Nephropathy
por: El-Kady, Mohamed M., et al.
Publicado: (2021)

Renoprotective Effect of KLF2 on Glomerular Endothelial Dysfunction in Hypertensive Nephropathy
por: Bae, Eunjin, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Potential Renoprotective Agents through Inhibiting CTGF/CCN2 in Diabetic Nephropathy
por: Wang, Songyan, et al.
Publicado: (2015)

A Review of Medicinal Plants with Renoprotective Activity in Diabetic Nephropathy Animal Models
por: Putra, I Made Wisnu Adhi, et al.
Publicado: (2023)

Renoprotective effects of stevia (Stevia rebaudiana Bertoni), amlodipine, valsartan, and losartan in gentamycin-induced nephrotoxicity in the rat model: Biochemical, hematological and histological approaches
por: Rizwan, Farhana, et al.
Publicado: (2019)

Improved renal survival in Japanese children with IgA nephropathy
por: Yata, Nahoko, et al.
Publicado: (2008)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

TWEAK/Fn14 system and crescent formation in IgA nephropathy
por: Sasaki, Yohei, et al.
Publicado: (2015)

Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats
por: Kaur, Manpreet, et al.
Publicado: (2015)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

A case of Waldenström's macroglobulinemia treated using clarithromycin and prednisolone
por: Ohe, Masashi, et al.
Publicado: (2017)

Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model
por: Lee, Mi Young, et al.
Publicado: (2011)

Erratum to: Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats
por: Kaur, Manpreet, et al.
Publicado: (2015)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_msva3l6plq61o307ri02pi1ots